By using this website you agree that we use cookies. You can find out more in the privacy policy.

Arizona Tribune - CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics

Arizona Tribune
×
NYSE - LSE
RBGPF 1.65% 83.78 $
SCS 0.12% 16.14 $
CMSD -0.17% 24.05 $
BCC 0.63% 80.81 $
RYCEF -2.69% 16 $
RIO -4.5% 91.03 $
RELX -1.03% 35.8 $
CMSC 0.21% 23.76 $
NGG 0.23% 85.27 $
JRI 1.07% 13.08 $
BTI 0.76% 60.68 $
BCE 1.43% 25.86 $
GSK 1.82% 51.6 $
AZN 0.19% 92.77 $
VOD -0.41% 14.65 $
BP -0.42% 37.88 $
CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics

CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics

BOULEVARD 16.12.2025

TAMPA, FL / ACCESS Newswire / December 16, 2025 / (OTCQB:CTTH) CTT Pharmaceutical Holdings, Inc. is pleased to announce that a peer-reviewed scientific paper has been published in the journal of Drug Delivery and Therapeutics, authored by our scientist Dr. Katharine Cole and Dr. Pankaj Modi, the founder of CTT Pharma. The article provides the first comprehensive scientific review describing how micellar nanotechnology, when combined with an oral dissolvable strip delivery system, can significantly improve the delivery and bioavailability of active therapeutic compounds. "This review article is an important step forward in bringing wider scientific attention to this innovative and transformative technology," said Dr. Cole.

Text size:

This publication is available on the Company's website www.cttpharmaceuticals.com in the 'Scientific Publications' section. This section includes peer-reviewed articles authored by CTT scientists that contribute to the broader scientific literature in areas relevant to the company's scientific focus. These publications are provided solely for transparency and informational purposes. Additional publications will be added as they become available.

CTT Pharma
813-606-0060

SOURCE: CTT Pharmaceutical Holdings, Inc.



View the original press release on ACCESS Newswire

A.Anderson--AT

Featured

Death toll from Swiss New Year bar fire rises to 41

Death toll from Swiss New Year bar fire rises to 41
Pakistan combing for perpetrators after deadly separatist attacks

Pakistan combing for perpetrators after deadly separatist attacks
Exiled Tibetans choose leaders for lost homeland

Exiled Tibetans choose leaders for lost homeland
Deportation raids drive Minneapolis immigrant family into hiding

Deportation raids drive Minneapolis immigrant family into hiding